PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 216.50
Bid: 216.00
Ask: 217.00
Change: 0.50 (0.23%)
Spread: 1.00 (0.463%)
Open: 214.50
High: 217.50
Low: 214.00
Prev. Close: 216.00
TCAP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Supplementary Prospectus

12 Sep 2016 15:49

RNS Number : 6000J
Tullett Prebon PLC
12 September 2016
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

This announcement is an advertisement for the purposes of the United Kingdom Prospectus Rules and not a prospectus and not an offer of securities for sale in any jurisdiction. Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Investors should not purchase or subscribe for any shares referred to in this announcement except on the basis of information in the Prospectus (as defined below), the First Supplementary Prospectus (as defined below), the Second Supplementary Prospectus (as defined below) and the Third Supplementary Prospectus (as defined below) published by Tullett Prebon plc today. This announcement does not constitute an offer of securities for sale, or an offer to acquire or exchange securities in the United States or in any other jurisdiction.

FOR IMMEDIATE RELEASE

12 September 2016

Tullett Prebon plc

Publication of Third Supplementary Prospectus

Further to the publication of a combined class 1 circular and prospectus (the "Prospectus") on 1 March 2016, a supplementary prospectus (the "First Supplementary Prospectus") on 5 April 2016 and a second supplementary prospectus (the "Second Supplementary Prospectus") on 16 May 2016 in connection with the proposed acquisition by Tullett Prebon plc ("Tullett Prebon") of the global hybrid voice broking and information business of ICAP plc ("ICAP") including ICAP's associated technology and broking platforms (including iSwap and Fusion) and certain of ICAP's joint ventures and associates (the "Transaction"), Tullett Prebon announces that it has published a third supplementary prospectus (the "Third Supplementary Prospectus").

The publication of the Third Supplementary Prospectus is a regulatory requirement under the Prospectus Rules following the entry into an amended acquisition agreement reflecting the change to the structure of the Transaction as set out in the announcement released by Tullett Prebon on 21 June 2016.

The Third Supplementary Prospectus has been approved by the UK Listing Authority and is available on Tullett Prebon's website, http://www.tullettprebon.com and will be submitted to the National Storage Mechanism, where it will be available for inspection at www.morningstar.co.uk/uk/nsm.do.

 

Enquiries

Tullett Prebon

Alexandra Wick (Marketing & Communications)

 

+44 (0)20 7200 7579

Rothschild (Financial Adviser and Sponsor to Tullett Prebon)

Stephen Fox

Toby Ross

 

+44 (0)20 7280 5000

HSBC (Joint Corporate Broker to Tullett Prebon)

Nick Donald

Peter Glover

 

+44 (0)20 7991 8888

Numis (Joint Corporate Broker to Tullett Prebon)

Michael Meade

Charles Farquhar

 

+44 (0)20 7260 1000

Brunswick

Kim Fletcher

Mike Smith

Craig Breheny

 

+44 (0)20 7404 5959

tullettprebon@brunswickgroup.com

Important notice

N M Rothschild & Sons Limited ("Rothschild"), which is authorised by the Prudential Regulatory Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting as sponsor and financial adviser to Tullett Prebon in connection with the Transaction. Rothschild is acting exclusively for Tullett Prebon and no-one else in connection with the Transaction and save for any responsibilities and liabilities, if any, which may be imposed on Rothschild, in its capacity as sponsor by the Financial Services and Markets Act 2000, as amended, Rothschild will not be responsible to anyone other than Tullett Prebon for providing the protections afforded to clients of Rothschild or for providing advice in relation to the Transaction or the contents of this announcement or any transaction, arrangement or matter referred to herein. The information provided in this announcement is entirely based on information provided by Tullett Prebon and has not been independently verified by Rothschild. Accordingly, Rothschild does not accept any responsibility or liability whatsoever, and makes no representations or warranty, express or implied, for the contents of this announcement. Rothschild disclaims, to the fullest extent permitted by law all and any responsibility and liability howsoever arising which it might otherwise have in respect of this announcement.

HSBC Bank plc ("HSBC"), which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority, is acting as Joint Corporate Broker to Tullett Prebon in connection with the Transaction. HSBC is acting exclusively for Tullett Prebon and no-one else in connection with the Transaction. HSBC will not be responsible to anyone other than Tullett Prebon for providing the protections afforded to clients of HSBC or for providing advice in relation to the Transaction or the contents of this announcement or any transaction, arrangement or matter referred to herein. The information provided in this announcement is entirely based on information provided by Tullett Prebon and has not been independently verified by HSBC. Accordingly, HSBC does not accept any responsibility or liability whatsoever, and makes no representations or warranty, express or implied, for the contents of this announcement. HSBC disclaims, to the fullest extent permitted by law all and any responsibility and liability howsoever arising which it might otherwise have in respect of this announcement.

Numis Securities Limited ("Numis"), which is authorised and regulated by the Financial Conduct Authority, is acting as Joint Corporate Broker to Tullett Prebon in connection with the Transaction. Numis is acting exclusively for Tullett Prebon and no-one else in connection with the Transaction. Numis will not be responsible to anyone other than Tullett Prebon for providing the protections afforded to clients of Numis or for providing advice in relation to the Transaction or the contents of this announcement or any transaction, arrangement or matter referred to herein. The information provided in this announcement is entirely based on information provided by Tullett Prebon and has not been independently verified by Numis. Accordingly, Numis does not accept any responsibility or liability whatsoever, and makes no representation or warranty, express or implied, for the contents of this announcement. Numis disclaims, to the fullest extent permitted by law all and any responsibility and liability howsoever arising which it might otherwise have in respect of this announcement.

This announcement has been issued by and is the sole responsibility of Tullett Prebon.

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities pursuant to this announcement or otherwise. The distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

This announcement does not constitute an offer of securities for sale in the United States or an offer to acquire or exchange securities in the United States. No offer to acquire securities or to exchange securities for other securities has been made, or will be made, and no offer of securities has been made, or will be made, directly or indirectly, in or into, or by use of the mails, any means or instrumentality of interstate or foreign commerce or any facilities of a national securities exchange of, the United States of America or any other country in which such offer may not be made other than (i) in accordance with the requirements under the US Securities Exchange Act of 1934, as amended, a registration statement under the US Securities Act of 1933, as amended, or the securities laws of such other country, as the case may be, or (ii) pursuant to an available exemption therefrom. No securities are intended to be registered under the US Securities Act of 1933, as amended.

This announcement has been prepared for the purposes of complying with the applicable law and regulation of the United Kingdom (including the Listing Rules, the disclosure requirements imposed by the Market Abuse Regulation (Regulation (EU) No 596/2014) and the Transparency Rules) and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of the United Kingdom.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PSPDMGMLDZZGVZM
Date   Source Headline
11th May 20227:00 amRNSTrading Statement
4th May 20224:27 pmRNSGrant of Options and Director/PDMR Shareholding
22nd Apr 20224:49 pmRNSHolding(s) in Company
11th Apr 20224:17 pmRNSHolding(s) in Company
5th Apr 202211:02 amRNSAnnual Financial Report
4th Apr 20224:03 pmRNSDirector/PDMR Shareholding
31st Mar 20226:03 pmRNSDirector/PDMR Shareholding
29th Mar 20225:44 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSFinal Results
11th Jan 202211:35 amRNSHolding(s) in Company
22nd Dec 20215:00 pmRNSAppointment of new director
13th Dec 20213:24 pmRNSDirector/PDMR Shareholding
12th Nov 20212:04 pmRNSShareholder meeting update and PDMR transactions
12th Nov 20211:57 pmRNSTotal Voting Rights
2nd Nov 20217:00 amRNSTrading update - three months ended 30/09/2021
11th Oct 20214:00 pmRNSDirector/PDMR Shareholding
11th Oct 20213:01 pmRNSParameta Solutions Investor Seminar
7th Oct 202110:40 amRNSDirector/PDMR Shareholding
20th Sep 20214:58 pmRNSDirector/PDMR Shareholding
8th Sep 20215:08 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf-year Report
3rd Aug 20217:00 amRNSTrading Statement
22nd Jun 20214:36 pmRNSDirector/PDMR Shareholding
18th May 202111:20 amRNSDirector/PDMR Shareholding
12th May 20215:49 pmRNSResult of AGM
12th May 20217:00 amRNSTrading Statement
23rd Apr 20215:10 pmRNSGrant of Options and Director/PDMR Shareholding
6th Apr 20214:32 pmRNSDirector/PDMR Shareholding - Replacement
1st Apr 20216:15 pmRNSDirector/PDMR Shareholding
26th Mar 20212:05 pmRNSAnnual Financial Report
10th Mar 20215:16 pmRNSRe-registration and name change
9th Mar 20217:03 amRNSFinal Results
26th Feb 20218:24 amRNSScheme Effective and Admission
24th Feb 20214:24 pmRNSCourt Sanction of the Scheme of Arrangement
18th Feb 20214:20 pmRNSHolding(s) in Company
17th Feb 20214:00 pmRNSDirector/PDMR Shareholding
17th Feb 20214:00 pmRNSTotal Voting Rights
17th Feb 202111:12 amRNSResults of Rump Placing
17th Feb 20217:00 amRNSResults of Rights Issue
16th Feb 20212:56 pmRNSHolding(s) in Company
2nd Feb 20218:00 amRNSAdmission of Nil Paid Rights
1st Feb 20214:05 pmRNSResults of Court Meeting and General Meeting
1st Feb 20213:55 pmRNSResult of General Meeting - Liquidnet Acquistion
29th Jan 20211:05 pmRNSPublication of Suppl.Prospcts
25th Jan 20217:00 amRNSUpdate on Brexit Readiness Plan
7th Jan 20211:44 pmRNSCorporate Reorganisation - Documents Publication
7th Jan 20211:40 pmRNSPublication of Prospectus and Circular
7th Jan 20217:00 amRNSAnnouncement re: Rights Issue
7th Jan 20217:00 amRNSTrading Statement
17th Dec 202012:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.